
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
New developments and opportunities in drugs being trialed for amyotrophic lateral sclerosis from 2020 to 2022
JingSi Jiang, Yan Wang, Min Deng
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 50
JingSi Jiang, Yan Wang, Min Deng
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 50
Showing 1-25 of 50 citing articles:
The Roles of Neutrophil-Derived Myeloperoxidase (MPO) in Diseases: The New Progress
Wei Lin, Huili Chen, Xijing Chen, et al.
Antioxidants (2024) Vol. 13, Iss. 1, pp. 132-132
Open Access | Times Cited: 59
Wei Lin, Huili Chen, Xijing Chen, et al.
Antioxidants (2024) Vol. 13, Iss. 1, pp. 132-132
Open Access | Times Cited: 59
The changing metabolic landscape of bile acids – keys to metabolism and immune regulation
Ipsita Mohanty, Celeste Allaband, Helena Mannochio-Russo, et al.
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 7, pp. 493-516
Closed Access | Times Cited: 59
Ipsita Mohanty, Celeste Allaband, Helena Mannochio-Russo, et al.
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 7, pp. 493-516
Closed Access | Times Cited: 59
Current State and Future Directions in the Therapy of ALS
Laura Tzeplaeff, Sibylle Wilfling, Maria Viktoria Requardt, et al.
Cells (2023) Vol. 12, Iss. 11, pp. 1523-1523
Open Access | Times Cited: 55
Laura Tzeplaeff, Sibylle Wilfling, Maria Viktoria Requardt, et al.
Cells (2023) Vol. 12, Iss. 11, pp. 1523-1523
Open Access | Times Cited: 55
Microglia and Astrocytes in Amyotrophic Lateral Sclerosis: Disease-Associated States, Pathological Roles, and Therapeutic Potential
Justin You, Mohieldin Youssef, Jhune Rizsan Santos, et al.
Biology (2023) Vol. 12, Iss. 10, pp. 1307-1307
Open Access | Times Cited: 23
Justin You, Mohieldin Youssef, Jhune Rizsan Santos, et al.
Biology (2023) Vol. 12, Iss. 10, pp. 1307-1307
Open Access | Times Cited: 23
From Brain to Muscle: The Role of Muscle Tissue in Neurodegenerative Disorders
Elisa Duranti, Chiara Villa
Biology (2024) Vol. 13, Iss. 9, pp. 719-719
Open Access | Times Cited: 8
Elisa Duranti, Chiara Villa
Biology (2024) Vol. 13, Iss. 9, pp. 719-719
Open Access | Times Cited: 8
AAV-NRIP gene therapy ameliorates motor neuron degeneration and muscle atrophy in ALS model mice
Hsin‐Hsiung Chen, Hsin-Tung Yeo, Yun‐Hsin Huang, et al.
Skeletal Muscle (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Hsin‐Hsiung Chen, Hsin-Tung Yeo, Yun‐Hsin Huang, et al.
Skeletal Muscle (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Riluzole-loaded lipid nanoparticles for brain delivery: Preparation, optimization and characterization
Maria Inês Teixeira, Carla M. Lopes, Hugo Gonçalves, et al.
Journal of Molecular Liquids (2023) Vol. 388, pp. 122749-122749
Open Access | Times Cited: 12
Maria Inês Teixeira, Carla M. Lopes, Hugo Gonçalves, et al.
Journal of Molecular Liquids (2023) Vol. 388, pp. 122749-122749
Open Access | Times Cited: 12
Muscle Matters: Transforming Amyotrophic Lateral Sclerosis Diagnostics with Next-Gen Biosensors and Smart Detection
Saumitra Singh, Sameer Khan, Shahbaz Khan, et al.
ACS Chemical Neuroscience (2025)
Closed Access
Saumitra Singh, Sameer Khan, Shahbaz Khan, et al.
ACS Chemical Neuroscience (2025)
Closed Access
Multifunctional nanoparticles for immune regulation and oxidative stress alleviation in myocarditis
Zhou Ye, Manman Zhu, Shaojie Li, et al.
Journal of Controlled Release (2025) Vol. 381, pp. 113607-113607
Closed Access
Zhou Ye, Manman Zhu, Shaojie Li, et al.
Journal of Controlled Release (2025) Vol. 381, pp. 113607-113607
Closed Access
Emerging Ferroptosis Involvement in Amyotrophic Lateral Sclerosis Pathogenesis: Neuroprotective Activity of Polyphenols
Annamaria Russo, Stefano Putaggio, Ester Tellone, et al.
Molecules (2025) Vol. 30, Iss. 6, pp. 1211-1211
Open Access
Annamaria Russo, Stefano Putaggio, Ester Tellone, et al.
Molecules (2025) Vol. 30, Iss. 6, pp. 1211-1211
Open Access
Nutritional Interventions in Amyotrophic Lateral Sclerosis: From Ketogenic Diet and Neuroprotective Nutrients to the Microbiota-Gut-Brain Axis Regulation
Samira Nabakhteh, Amir Lotfi, Arman Afsartaha, et al.
Molecular Neurobiology (2025)
Closed Access
Samira Nabakhteh, Amir Lotfi, Arman Afsartaha, et al.
Molecular Neurobiology (2025)
Closed Access
5-Repurposed Drug Candidates Identified in Motor Neurons and Muscle Tissues with Amyotrophic Lateral Sclerosis by Network Biology and Machine Learning Based on Gene Expression
Kubra Temiz, Aytaç Gül, Esra Göv
NeuroMolecular Medicine (2025) Vol. 27, Iss. 1
Open Access
Kubra Temiz, Aytaç Gül, Esra Göv
NeuroMolecular Medicine (2025) Vol. 27, Iss. 1
Open Access
Reduction of inflammation and mitochondrial degeneration in mutant SOD1 mice through inhibition of voltage-gated potassium channel Kv1.3
Patrizia Ratano, Germana Cocozza, Cecilia Pinchera, et al.
Frontiers in Molecular Neuroscience (2024) Vol. 16
Open Access | Times Cited: 3
Patrizia Ratano, Germana Cocozza, Cecilia Pinchera, et al.
Frontiers in Molecular Neuroscience (2024) Vol. 16
Open Access | Times Cited: 3
Mitochondrial Dysfunction in Sporadic Amyotrophic Lateral Sclerosis Patients: Insights from High-Resolution Respirometry
Petra Parvanovova, Andrea Evinová, Milan Grofik, et al.
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1294-1294
Open Access | Times Cited: 3
Petra Parvanovova, Andrea Evinová, Milan Grofik, et al.
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1294-1294
Open Access | Times Cited: 3
Novel Prospects in Targeting Neurodegenerative Disorders via Autophagy
Shumayila Khan, Saurabh Upadhyay, Md. Imtaiyaz Hassan
European Journal of Pharmacology (2024) Vol. 984, pp. 177060-177060
Closed Access | Times Cited: 3
Shumayila Khan, Saurabh Upadhyay, Md. Imtaiyaz Hassan
European Journal of Pharmacology (2024) Vol. 984, pp. 177060-177060
Closed Access | Times Cited: 3
Unraveling the Multifaceted Insights into Amyotrophic Lateral Sclerosis: Genetic Underpinnings, Pathogenesis, and Therapeutic Horizons
Ramaish Sharma, Zuber Khan, Sidharth Mehan, et al.
Mutation Research/Reviews in Mutation Research (2024) Vol. 794, pp. 108518-108518
Closed Access | Times Cited: 3
Ramaish Sharma, Zuber Khan, Sidharth Mehan, et al.
Mutation Research/Reviews in Mutation Research (2024) Vol. 794, pp. 108518-108518
Closed Access | Times Cited: 3
Antisense therapy: a potential breakthrough in the treatment of neurodegenerative diseases
Roberta Romanò, Cecilia Bucci
Neural Regeneration Research (2023) Vol. 19, Iss. 5, pp. 1027-1035
Open Access | Times Cited: 7
Roberta Romanò, Cecilia Bucci
Neural Regeneration Research (2023) Vol. 19, Iss. 5, pp. 1027-1035
Open Access | Times Cited: 7
Pathological mechanisms of amyotrophic lateral sclerosis
Yushu Hu, Wenzhi Chen, Caihui Wei, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 5, pp. 1036-1044
Open Access | Times Cited: 7
Yushu Hu, Wenzhi Chen, Caihui Wei, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 5, pp. 1036-1044
Open Access | Times Cited: 7
Advances in Understanding and Treating Amyotrophic Lateral Sclerosis (ALS): A Comprehensive Review
Deepal Gupta, Sunita Vagha, Hitaansh Dhingra, et al.
Cureus (2023)
Open Access | Times Cited: 7
Deepal Gupta, Sunita Vagha, Hitaansh Dhingra, et al.
Cureus (2023)
Open Access | Times Cited: 7
CNM-Au8: an experimental agent for the treatment of amyotrophic lateral sclerosis (ALS)
J. Daniel Bireley, John A. Morren
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 8, pp. 677-683
Closed Access | Times Cited: 6
J. Daniel Bireley, John A. Morren
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 8, pp. 677-683
Closed Access | Times Cited: 6
Sigma-1 receptor agonism exacerbates immune-driven nociception: Role of TRPV1 + nociceptors
M. Carmen Ruiz‐Cantero, Miguel Á. Huerta, Miguel Á. Tejada, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115534-115534
Open Access | Times Cited: 5
M. Carmen Ruiz‐Cantero, Miguel Á. Huerta, Miguel Á. Tejada, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115534-115534
Open Access | Times Cited: 5
New Adamantane-Containing Edaravone Conjugates as Potential Neuroprotective Agents for ALS Treatments
M. A. Lapshina, E. F. Shevtsova, V. V. Grigoriev, et al.
Molecules (2023) Vol. 28, Iss. 22, pp. 7567-7567
Open Access | Times Cited: 5
M. A. Lapshina, E. F. Shevtsova, V. V. Grigoriev, et al.
Molecules (2023) Vol. 28, Iss. 22, pp. 7567-7567
Open Access | Times Cited: 5
Computational analysis of five neurodegenerative diseases reveals shared and specific genetic loci
Francesca Maselli, Salvatore D’Antona, Mattia Utichi, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 5395-5407
Open Access | Times Cited: 4
Francesca Maselli, Salvatore D’Antona, Mattia Utichi, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 5395-5407
Open Access | Times Cited: 4
Development of novel treatments for amyotrophic lateral sclerosis
Zhuo Sun, Bo Zhang, Ying Peng
Metabolic Brain Disease (2023) Vol. 39, Iss. 3, pp. 467-482
Closed Access | Times Cited: 4
Zhuo Sun, Bo Zhang, Ying Peng
Metabolic Brain Disease (2023) Vol. 39, Iss. 3, pp. 467-482
Closed Access | Times Cited: 4
Navigating the Frontiers of Machine Learning in Neurodegenerative Disease Therapeutics
Yoonjeong Cha, Mohamedi N. Kagalwala, Jermaine Ross
Pharmaceuticals (2024) Vol. 17, Iss. 2, pp. 158-158
Open Access | Times Cited: 1
Yoonjeong Cha, Mohamedi N. Kagalwala, Jermaine Ross
Pharmaceuticals (2024) Vol. 17, Iss. 2, pp. 158-158
Open Access | Times Cited: 1